Profile of:

Astrid Van Tubergen

Full name: Astrid Van Tubergen

Current country: Netherlands

Membership level: Full

Type of membership: Member

Number of publications: 15

Effectiveness and cost-effectiveness of combined asynchronous telemonitoring and patient-initiated care for spondyloarthritis: protocol for a pragmatic multicentre randomised controlled trial (TeleSpA-study). (2023)

Treating spondyloarthritis early: does it matter? Results from a systematic literature review. (2023)

Go or no-go for treat-to-target in axial spondyloarthritis? (2023)

Development of a web-based decision aid for initiating biologic or targeted synthetic disease modifying anti-rheumatic drugs (b/tsDMARDs) in axial spondyloarthritis. (2023)

Treat-to-target in axial spondyloarthritis: an observational study in daily practice (2022)

How is early spondyloarthritis defined in the literature? Results from a systematic review (2022)

Are all routine spondyloarthritis outpatient visits considered useful by rheumatologists? An explorative clinical practice study. (2022)

The impact of the COVID-19 pandemic on work productivity in patients with spondyloarthritis: results from the Dutch SpA-Net registry. (2022)

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial (2021)

Progression from subclinical inflammation to overt SpA in first degree relatives of SpA patients is associated with HLA-B27: the Pre-SpA cohort (2021)

Development and validation of an alternative ankylosing spondylitis disease activity score when patient global assessment is unavailable (2021)

Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT) (2020)

Validation and implementation of a patient-reported experience measure for patients with rheumatoid arthritis and spondyloarthritis in the Netherlands (2020)

Validation of the self-administered comorbidity questionnaire adjusted for spondyloarthritis: results from the ASAS-COMOSPA study (2020)

Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis (2020)